Ctrx | search
Click here to view Ctrx news from 60+ newspapers.
Bookmark or Share- Citius Pharmaceuticals, Inc. - Unlocking Potential. Faster.Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in oncology, adjunct cancer care, stem cell therapy and unique prescription products. Read more. Why Invest. 4.
- Citius Pharmaceuticals Inc (CTXR) Stock Price & News - GoogleCitius Pharmaceuticals Inc (CTXR) Stock Price & News - Google Finance. Home CTXR • NASDAQ. Citius Pharmaceuticals Inc. Share. $0.68. After Hours: $0.68. (0.00%) 0.00. Closed: May 31,...
- CTXR Stock Price | Citius Pharmaceuticals Inc. Stock Quote (U.S ...Citius Pharmaceuticals Inc. Watch list. NEW. Set a price target alert. After Hours. Last Updated: May 31, 2024 7:59 p.m. EDT Delayed quote. $ 0.7000. 0.00 0.36% After Hours Volume: 29.02K....
- Citius Pharmaceuticals, Inc. (CTXR) - Yahoo FinanceCitius Pharmaceuticals, Inc. (CTXR) 0.6556 +0.0256 (+4.06%) At close: May 30 at 4:00 PM EDT. 0.6511 -0.00 (-0.69%) After hours: May 30 at 6:30 PM EDT. 1D. 5D. 3M. 6M. YTD. 1Y. 5Y. All. Key...
- Citius Pharmaceuticals, Inc. (CTXR) - Stock AnalysisCitius Pharmaceuticals, Inc. (CTXR) Stock Price, Quote & News - Stock Analysis. NASDAQ: CTXR · IEX Real-Time Price · USD. 0.656. +0.026 (4.06%) At close: May 30, 2024, 4:00 PM. 0.651. -0.005 (-0.70%) After-hours: May 30, 2024, 7:59 PM EDT. Overview. Financials. Statistics. Forecast. Profile. Chart. 1D. 5D. 1M. YTD. 1Y. 5Y. Max. 4.06% ( 1D) News.
More
